These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33999256)

  • 1. Ultrastructural characterization of peripheral denervation in a mouse model of Type III spinal muscular atrophy.
    Fulceri F; Biagioni F; Limanaqi F; Busceti CL; Ryskalin L; Lenzi P; Fornai F
    J Neural Transm (Vienna); 2021 Jun; 128(6):771-791. PubMed ID: 33999256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy.
    Deguise MO; De Repentigny Y; Tierney A; Beauvais A; Michaud J; Chehade L; Thabet M; Paul B; Reilly A; Gagnon S; Renaud JM; Kothary R
    EBioMedicine; 2020 May; 55():102750. PubMed ID: 32339936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.
    Murray LM; Comley LH; Thomson D; Parkinson N; Talbot K; Gillingwater TH
    Hum Mol Genet; 2008 Apr; 17(7):949-62. PubMed ID: 18065780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA).
    Feng Z; Lam S; Tenn ES; Ghosh AS; Cantor S; Zhang W; Yen PF; Chen KS; Burden S; Paushkin S; Ayalon G; Ko CP
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense Oligonucleotides.
    Lin TL; Chen TH; Hsu YY; Cheng YH; Juang BT; Jong YJ
    PLoS One; 2016; 11(4):e0154723. PubMed ID: 27124114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice.
    Meijboom KE; Sutton ER; McCallion E; McFall E; Anthony D; Edwards B; Kubinski S; Tapken I; Bünermann I; Hazell G; Ahlskog N; Claus P; Davies KE; Kothary R; Wood MJA; Bowerman M
    Skelet Muscle; 2022 Jul; 12(1):18. PubMed ID: 35902978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. At the "junction" of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression.
    Goulet BB; Kothary R; Parks RJ
    Curr Mol Med; 2013 Aug; 13(7):1160-74. PubMed ID: 23514457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene.
    Park GH; Maeno-Hikichi Y; Awano T; Landmesser LT; Monani UR
    J Neurosci; 2010 Sep; 30(36):12005-19. PubMed ID: 20826664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compensatory axon sprouting for very slow axonal die-back in a transgenic model of spinal muscular atrophy type III.
    Udina E; Putman CT; Harris LR; Tyreman N; Cook VE; Gordon T
    J Physiol; 2017 Mar; 595(5):1815-1829. PubMed ID: 27891608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural changes in diaphragm neuromuscular junctions in a severe mouse model for Spinal Muscular Atrophy and their prevention by bifunctional U7 snRNA correcting SMN2 splicing.
    Voigt T; Meyer K; Baum O; Schümperli D
    Neuromuscul Disord; 2010 Nov; 20(11):744-52. PubMed ID: 20832308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models of SMA show divergent patterns of neuronal vulnerability and resilience.
    Woschitz V; Mei I; Hedlund E; Murray LM
    Skelet Muscle; 2022 Sep; 12(1):22. PubMed ID: 36089582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy.
    Kannan A; Jiang X; He L; Ahmad S; Gangwani L
    Brain; 2020 Jan; 143(1):69-93. PubMed ID: 31828288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology.
    Bowerman M; Murray LM; Beauvais A; Pinheiro B; Kothary R
    Neuromuscul Disord; 2012 Mar; 22(3):263-76. PubMed ID: 22071333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of SMN protein in mesenchymal progenitors impairs the development of bone and neuromuscular junction in spinal muscular atrophy.
    Hann SH; Kim SY; Kim YL; Jo YW; Kang JS; Park H; Choi SY; Kong YY
    Elife; 2024 Feb; 12():. PubMed ID: 38318851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice.
    Kim JK; Caine C; Awano T; Herbst R; Monani UR
    Hum Mol Genet; 2017 Jul; 26(13):2377-2385. PubMed ID: 28379354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice.
    Tsai LK; Tsai MS; Ting CH; Li H
    J Mol Med (Berl); 2008 Nov; 86(11):1243-54. PubMed ID: 18649067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis.
    Janzen E; Mendoza-Ferreira N; Hosseinibarkooie S; Schneider S; Hupperich K; Tschanz T; Grysko V; Riessland M; Hammerschmidt M; Rigo F; Bennett CF; Kye MJ; Torres-Benito L; Wirth B
    Brain; 2018 Aug; 141(8):2343-2361. PubMed ID: 29961886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.
    Martinez TL; Kong L; Wang X; Osborne MA; Crowder ME; Van Meerbeke JP; Xu X; Davis C; Wooley J; Goldhamer DJ; Lutz CM; Rich MM; Sumner CJ
    J Neurosci; 2012 Jun; 32(25):8703-15. PubMed ID: 22723710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
    Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
    Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.